We have previously illustrated the capacity of SVAs to influence gene expressions within Parkinson’s disease, highlighting the role of SVA_67 to modulate genes at the MAPT locus within the PPMI cohort and a CRISPR deletion model [27,32,40]. Here, MAPT is linked to Parkinson disease.